Alkem Laboratories Limited Alkem Laboratories Limited

Alkem Laboratories Limited

ALKEM

Classifica tra le azioni #2812
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Prezzo delle azioni
$55.19
Capitalizzazione di mercato
$6.60B
Variazione (1 giorno)
-0.06%
Variazione (1 anno)
-12.43%
Paese
IN
Scambia Alkem Laboratories Limited (ALKEM)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Alkem Laboratories Limited (ALKEM)
L’azione Alkem Laboratories Limited (simbolo: ALKEM) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 21, 2026.
Una quota di ALKEM acquistata prima di Oct 21, 2026 equivale oggi a 0 quote di ALKEM.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti